Catalogo Articoli (Spogli Riviste)

HELP
ATTENZIONE: attualmente gli articoli Current Contents (fonte ISI) a partire dall'anno 2002 sono consultabili sulla Risorsa On-Line

Le informazioni sugli articoli di fonte ISI sono coperte da copyright

La ricerca find articoli where authors phrase all words 'Weigmann, H' sort by level,fasc_key/DESCEND, pagina_ini_num/ASCEND ha restituito 21 riferimenti
Selezionare un intervallo

Per ulteriori informazioni selezionare i riferimenti di interesse.

    1. Weigmann, H; Hartter, S; Maehrlein, S; Kiefer, W; Kramer, G; Dannhardt, G; Hiemke, C
      Simultaneous determination of olanzapine, clozapine and demethylated metabolites in serum by on-line column-switching high-performance liquid chromatography

      JOURNAL OF CHROMATOGRAPHY B
    2. Hartter, S; Wang, XM; Weigmann, H; Friedberg, T; Arand, M; Oesch, F; Hiemke, C
      Differential effects of fluvoxamine and other antidepressants on the biotransformation of melatonin

      JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY
    3. Weigmann, H; Gerek, S; Zeisig, A; Muller, M; Hartter, S; Hiemke, C
      Fluvoxamine but not sertraline inhibits the metabolism of olanzapine: Evidence from a therapeutic drug monitoring service

      THERAPEUTIC DRUG MONITORING
    4. Hartter, S; Weigmann, H; Hiemke, C
      Automated determination of reboxetine by high-performance liquid chromatography with column-switching and ultraviolet detection

      JOURNAL OF CHROMATOGRAPHY B
    5. Weigmann, H; Hartter, S; Bagli, M; Hiemke, C
      Steady state concentrations of clomipramine and its major metabolite desmethylclomipramine in rat brain and serum after oral administration of clomipramine

      EUROPEAN NEUROPSYCHOPHARMACOLOGY
    6. Hartter, S; Grozinger, M; Weigmann, H; Roschke, J; Hiemke, C
      Increased bioavailability of oral melatonin after fluvoxamine coadministration

      CLINICAL PHARMACOLOGY & THERAPEUTICS
    7. Ulrich, S; Kruggel, S; Weigmann, H; Hiemke, C
      Fishing for a drug: solid-phase microextraction for the assay of clozapinein human plasma

      JOURNAL OF CHROMATOGRAPHY B
    8. Weigmann, H; Hartter, S; Fischer, V; Dahmen, N; Hiemke, C
      Distribution of clozapine and desmethylclozapine between blood and brain in rats

      EUROPEAN NEUROPSYCHOPHARMACOLOGY
    9. Schmitt, U; Dahmen, N; Fischer, V; Weigmann, H; Rao, ML; Reuss, S; Hiemke, C
      Chronic oral haloperidol and clozapine in rats: A behavioral evaluation

      NEUROPSYCHOBIOLOGY
    10. Szegedi, A; Anghelescu, I; Wiesner, J; Schlegel, S; Weigmann, H; Hartter, S; Hiemke, C; Wetzel, H
      Addition of low-dose fluvoxamine to low-dose clozapine monotherapy in schizophrenia: Drug monitoring and tolerability data from a prospective clinical trial

      PHARMACOPSYCHIATRY
    11. Lammers, CH; Deuschle, M; Weigmann, H; Hartter, S; Hiemke, C; Heese, C; Heuser, I
      Coadministration of clozapine and fluvoxamine in psychotic patients - Clinical experience

      PHARMACOPSYCHIATRY
    12. HARTTER S; JENSEN B; HIEMKE C; LEAL M; WEIGMANN H; UNGER K
      MICELLAR ELECTROKINETIC CAPILLARY CHROMATOGRAPHY FOR THERAPEUTIC DRUG-MONITORING OF CARBAMAZEPINE AND ITS MAIN METABOLITES

      Journal of chromatography B. Biomedical sciences and applications
    13. WEIGMANN H; HARTTER S; HIEMKE C
      AUTOMATED-DETERMINATION OF CLOMIPRAMINE AND ITS MAJOR METABOLITES IN HUMAN AND RAT SERUM BY HIGH-PERFORMANCE LIQUID-CHROMATOGRAPHY WITH ONLINE COLUMN-SWITCHING

      Journal of chromatography B. Biomedical sciences and applications
    14. Anghelescu, I; Szegedi, A; Schlegel, S; Weigmann, H; Hiemke, C; Wetzel, H
      Combination treatment with clozapine and paroxetine in schizophrenia: safety and tolerability data from a prospective open clinical trial

      EUROPEAN NEUROPSYCHOPHARMACOLOGY
    15. WAGEMANS C; BIEBER R; WEIGMANN H; GELTENBORT P
      DETERMINATION OF THE THERMAL-NEUTRON INDUCED CA-41(N,P)K-41 AND CA-41(N,ALPHA)AR-38 REACTION CROSS-SECTIONS

      Physical review. C. Nuclear physics
    16. FISCHER V; SCHMITT U; WEIGMANN H; VONKELLER B; REUSS S; HIEMKE C; DAHMEN N
      CHRONICAL HALOPERIDOL AND CLOZAPINE TREATMENT IN RATS - DIFFERENTIAL RNA DISPLAY ANALYSIS, BEHAVIORAL-STUDIES AND SERUM LEVEL DETERMINATION

      Progress in neuro-psychopharmacology & biological psychiatry
    17. WETZEL H; ANGHELESCU I; SZEGEDI A; WIESNER J; WEIGMANN H; HARTTER S; HIEMKE C
      PHARMACOKINETIC INTERACTIONS OF CLOZAPINE WITH SELECTIVE SEROTONIN REUPTAKE INHIBITORS - DIFFERENTIAL-EFFECTS OF FLUVOXAMINE AND PAROXETINEIN A PROSPECTIVE-STUDY

      Journal of clinical psychopharmacology
    18. WEIGMANN H; BIERBRAUER J; HARTTER S; HIEMKE C
      AUTOMATED-DETERMINATION OF CLOZAPINE AND MAJOR METABOLITES IN SERUM AND URINE

      Therapeutic drug monitoring
    19. OBERSTEDT S; THEOBALD JP; WEIGMANN H; WARTENA JA; BURKHOLZ C
      INTERMEDIATE STRUCTURE AND THE SHAPE ISOMER IN TH-233

      Nuclear physics. A
    20. OBERSTEDT S; THEOBALD JP; WEIGMANN H; WARTENA JA; BURKHOLZ C
      LIMITS ON THE HALF-LIFE OF THE SHAPE ISOMER IN U-239

      Nuclear physics. A
    21. HIEMKE C; WEIGMANN H; HARTTER S; DAHMEN N; WETZEL H; MULLER H
      ELEVATED LEVELS OF CLOZAPINE IN SERUM AFTER ADDITION OF FLUVOXAMINE

      Journal of clinical psychopharmacology


ASDD Area Sistemi Dipartimentali e Documentali, Università di Bologna, Catalogo delle riviste ed altri periodici
Documento generato il 12/12/19 alle ore 15:06:14